As of 2024-12-14, the Fair Value of Inozyme Pharma Inc (INZY) is -7.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.03 USD, the upside of Inozyme Pharma Inc is -347.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -19.72 | -56.42 | -56.62 | -67.06 | -71.17 | -54.20 |
| YoY growth | -183.33% | -186.11% | -0.35% | -18.44% | -6.13% | -78.87% |
| Market Cap (mil) | 194.65 |
| P/E | |
| Forward P/E |
| EPS | -1.50 |
| Avg earnings growth rate | -78.87% |
| TTM earnings | -96.49 |